Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._1 type RangedSequencePosition NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60.assertion.
- NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._1 type SO_0001148 NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60.assertion.
- NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._1 comment "Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-222 and E-224. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-224. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-161 and/or E-187." NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60.assertion.
- NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._1 SIO_000053 NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._2 NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60.assertion.
- NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._1 SIO_000053 NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60._3 NX_O95863-1_MUTAGEN_220_220.RAj16zqcS08isdQcd2gn2RvqmK9qkoHrxdVEKm-wJoM60.assertion.